InvestorsHub Logo
Followers 30
Posts 4264
Boards Moderated 0
Alias Born 03/20/2011

Re: Solarfuture post# 114

Saturday, 11/04/2023 9:26:54 AM

Saturday, November 04, 2023 9:26:54 AM

Post# of 154
I concur, sentiment reversal with buying pressure now.

According to the latest presentation, should be a clinical update in Q4/23 in IMA203 - ref. page 27

https://investors.immatics.com/static-files/0df36fcf-308b-4e29-afe7-c83c562abab6

Also, if you put the latest press release regarding RMAT designation for IMA203 into the context of the above presentation, FDA approval of IMA203 is a possibility in 2024, imo.
( that could be taken as a bold statement, however, imo IMTX is doing an awesome job in all departments.)

RMAT Press Release:
https://investors.immatics.com/news-releases/news-release-details/immatics-receives-fda-regenerative-medicine-advanced-therapy-0
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMTX News